TD Waterhouse Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$647K	Buy	1,971 +1,641	+497%	+$558K	﹤0.01%	780
2025 Q4	$131K	Hold	330	–	–	﹤0.01%	978
2025 Q3	$152K	Buy	330 +300	+1,000%	+$122K	﹤0.01%	934
2025 Q2	$9.65K	Hold	30	–	–	﹤0.01%	1461
2025 Q1	$7.64K	Hold	30	–	–	﹤0.01%	1455
2024 Q4	$7.06K	Hold	30	–	–	﹤0.01%	1479
2024 Q3	$8.26K	Sell	30 -806	-96%	-$210K	﹤0.01%	1395
2024 Q2	$203K	Sell	836 -9	-1%	-$1.42K	﹤0.01%	764
2024 Q1	$131K	Buy	845 +31	+4%	+$5.17K	﹤0.01%	848
2023 Q4	$159K	Sell	814 -26	-3%	-$4.43K	﹤0.01%	721
2023 Q3	$154K	Sell	840 -50	-6%	-$9.54K	﹤0.01%	684
2023 Q2	$172K	Sell	890 -41	-4%	-$8.13K	﹤0.01%	686
2023 Q1	$191K	Sell	931 -4	-0.4%	-$841	﹤0.01%	660
2022 Q4	$223K	Sell	935 -199	-18%	-$42.4K	﹤0.01%	632
2022 Q3	$227K	Sell	1,134 -1,678	-60%	-$320K	﹤0.01%	646
2022 Q2	$422K	Sell	2,812 -35	-1%	-$4.96K	﹤0.01%	576
2022 Q1	$489K	Sell	2,847 -29	-1%	-$4.42K	﹤0.01%	595
2021 Q4	$482K	Buy	+2,876	New	+$535K	﹤0.01%	614